Jeffrey N. Miner

Insider

First SEC filing: March 10, 2021 · Latest: March 10, 2021

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 7 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Aug. 31, 2022	VIVS	A	40,000	—	—	40,000 Direct	—	Acquired	(price as of 2026-08-20)
Oct. 7, 2021	VIVS	A	52,023	—	—	52,023 Direct	—	Acquired	(price as of 2026-08-20)
Oct. 7, 2021	VIVS	A	12,500	—	—	12,500 Direct	—	Acquired	(price as of 2026-08-20)
Oct. 7, 2021	VIVS	A	12,500	—	—	12,500 Direct	—	Acquired	(price as of 2026-08-20)
March 8, 2021	VIVS	A	12,500	—	—	12,500 Direct	—	Acquired	(price as of 2026-08-20)
March 8, 2021	VIVS	A	12,500	—	—	12,500 Direct	—	Acquired	(price as of 2026-08-20)
Sept. 15, 2020	VIVS	A	100,000	—	—	100,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Aug. 31, 2022	VIVS	Stock Option (Right to Buy)	Common Stock (40,000)	$2.36	Aug. 31, 2032	40,000	Acquired
Oct. 7, 2021	VIVS	Stock Option (Right to Buy)	Common Stock (52,023)	$6.70	Oct. 7, 2031	52,023	Acquired
Oct. 7, 2021	VIVS	Stock Option (Right to Buy)	Common Stock (12,500)	$6.70	Oct. 7, 2031	12,500	Acquired
Oct. 7, 2021	VIVS	Stock Option (Right to Buy)	Common Stock (12,500)	$6.70	Oct. 7, 2031	12,500	Acquired
March 8, 2021	VIVS	Stock Option (Right to Buy)	Common Stock (12,500)	$10.27	March 8, 2031	12,500	Acquired
March 8, 2021	VIVS	Stock Option (Right to Buy)	Common Stock (12,500)	$10.27	March 8, 2031	12,500	Acquired
Sept. 15, 2020	VIVS	Stock Option (Right to Buy)	Common Stock (100,000)	$7.64	Sept. 15, 2030	100,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Chief Scientific Officer(7)

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2022	$225,000	—	—	$443,247	$78,750	—	—	$747,027
2021	$120,288	—	—	$833,028	—	—	—	$953,317

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.